Back to top

dna-sequencing: Archive

Zacks Equity Research

CRISPR (CRSP) Q4 Earnings Top on Collaboration Revenues, Stock Up

CRISPR (CRSP) gains on encouraging fourth-quarter 2023 results, beating both earnings and revenue estimates on the back of collaboration revenues received from Vertex.

VRTXPositive Net Change PBYIPositive Net Change ADMAPositive Net Change CRSPPositive Net Change

Zacks Equity Research

Inovio Pharma (INO) Stock Rallies 134% in a Month: Here's Why

Inovio Pharma (INO) surges 134% in a month, mainly due to its plans to submit a regulatory application seeking approval of its lead candidate, INO-3107, in the second half of 2024 to treat RRP.

INOPositive Net Change PBYIPositive Net Change ADMAPositive Net Change CHRSPositive Net Change